Insmed Incorporated (0JAV.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 34.67B |
| Enterprise Value | 34.93B |
| P/E Ratio | -42.82 |
| PEG Ratio | -0.54 |
| Price/Sales Ratio | 17.43 |
| Price/Book Ratio | 36.38 |
| Enterprise/Revenue | 17.66 |
| Enterprise/EBITDA | -54.33 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.4 |
| Operating Margin | -0.36 |
| Return On Assets | -0.27 |
| Return On Equity | -0.83 |
| Revenue | 606.42M |
| Revenue/Share | 6.95 |
| Gross Profit | 477.48M |
| EBITDA | -978.33M |
| Net Income | -1.28B |
| Diluted EPS | -6.42 |
| Total Cash | 1.15B |
| Total Cash/Share | 5.24 |
| Total Debt | 749.77M |
| Total Debt/Equity | 1.02 |
| Current Ratio | 2.86 |
| Book Value Per Share | 3.32 |
| 52-Week Change | -37.93 |
| 52-Week High | 214 |
| 52-Week Low | 91.59 |
| Moving Average 50 Days | 111.05 |
| Moving Average 200 Days | 123.83 |
| Average Volume | 1,805 |
| Shares Outstanding | 219.38M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |